These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37762239)

  • 21. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
    Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
    Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.
    Shen M; Guo L; Zhang H; Zheng B; Liu X; Gu J; Yang T; Sun C; Yi X
    J Nanobiotechnology; 2024 Jun; 22(1):310. PubMed ID: 38831378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP-Responsive Manganese-Based Bacterial Materials Synergistically Activate the cGAS-STING Pathway for Tumor Immunotherapy.
    Yang H; Yang S; Guo Q; Sheng J; Mao Z
    Adv Mater; 2024 Jun; 36(23):e2310189. PubMed ID: 38414097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.
    Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT
    J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
    Wheeler OPG; Unterholzner L
    Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
    Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
    Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mn-based cGAS-STING activation for tumor therapy.
    Huang A; Zhou W
    Chin J Cancer Res; 2023 Feb; 35(1):19-43. PubMed ID: 36910853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
    Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
    Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Radiosensitization Nanoagent to Activate cGAS-STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy.
    Wu Z; Li Q; Zhu K; Zheng S; Hu H; Hou M; Qi L; Chen S; Xu Y; Zhao B; Yan C
    Adv Healthc Mater; 2024 Jun; 13(14):e2303626. PubMed ID: 38387885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.
    Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S
    Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination of STING agonist with anti-vascular RGD-(KLAKLAK)
    Czapla J; Drzyzga A; Ciepła J; Matuszczak S; Jarosz-Biej M; Pilny E; Cichoń T; Smolarczyk R
    Cancer Immunol Immunother; 2024 Jun; 73(8):148. PubMed ID: 38832958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cGAS-STING pathway in cancer biotherapy.
    Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
    Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.
    Bose D
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manganese-enriched photonic/catalytic nanomedicine augments synergistic anti-TNBC photothermal/nanocatalytic/immuno-therapy via activating cGAS-STING pathway.
    Zheng Y; Chen J; Song XR; Chang MQ; Feng W; Huang H; Jia CX; Ding L; Chen Y; Wu R
    Biomaterials; 2023 Feb; 293():121988. PubMed ID: 36580716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.